GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » PS Ratio

Mankind Pharma (BOM:543904) PS Ratio : 11.37 (As of May. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Mankind Pharma's share price is ₹2238.15. Mankind Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹196.86. Hence, Mankind Pharma's PS Ratio for today is 11.37.

Warning Sign:

Mankind Pharma Ltd stock PS Ratio (=11.37) is close to 2-year high of 12.03

The historical rank and industry rank for Mankind Pharma's PS Ratio or its related term are showing as below:

BOM:543904' s PS Ratio Range Over the Past 10 Years
Min: 6.29   Med: 10.36   Max: 12.03
Current: 11.37

During the past 3 years, Mankind Pharma's highest PS Ratio was 12.03. The lowest was 6.29. And the median was 10.36.

BOM:543904's PS Ratio is ranked worse than
90.24% of 1004 companies
in the Drug Manufacturers industry
Industry Median: 2.21 vs BOM:543904: 11.37

Mankind Pharma's Revenue per Sharefor the three months ended in Dec. 2023 was ₹64.98. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹196.86.

During the past 12 months, the average Revenue per Share Growth Rate of Mankind Pharma was 57.60% per year.

Back to Basics: PS Ratio


Mankind Pharma PS Ratio Historical Data

The historical data trend for Mankind Pharma's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma PS Ratio Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22
PS Ratio
- - -

Mankind Pharma Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 9.63 9.74 10.07

Competitive Comparison of Mankind Pharma's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Mankind Pharma's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mankind Pharma's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mankind Pharma's PS Ratio distribution charts can be found below:

* The bar in red indicates where Mankind Pharma's PS Ratio falls into.



Mankind Pharma PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Mankind Pharma's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=2238.15/196.86
=11.37

Mankind Pharma's Share Price of today is ₹2238.15.
Mankind Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹196.86.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Mankind Pharma  (BOM:543904) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Mankind Pharma PS Ratio Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mankind Pharma (BOM:543904) Business Description

Traded in Other Exchanges
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines